Canine CK-MB antibody and antigen (recombinant protein)
Diagnostic anti-Canine CK-MB antibodies pairs and antigen for animal health (animal Dog/Canine Myocardial hypoxia) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-CAN-CK-MB-Ag01 | Recombinant Canine CK-MB protein | 3090 |
GMP-CAN-CK-MB-Ab01 | Anti-Canine CK-MB mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-CK-MB-Ab02 | Anti-Canine CK-MB mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-CK-MB-Ab03 | Anti-Canine CK-MB human monoclonal antibody (mAb) | 1953 |
GMP-CAN-CK-MB-Ab04 | Anti-Canine CK-MB human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-CAN-CK-MB-Ag01 |
Product Name | Recombinant Canine CK-MB protein |
Target/Biomarker | Canine Creatine Kinase MB (A1M) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine Creatine Kinase MB antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in A1M level test of animal Dog/Canine with Myocardial hypoxia. |
Tag | His |
Products description | Recombinant Canine CK-MB protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-CK-MB-Ab01, GMP-CAN-CK-MB-Ab02 |
Product Name | Anti-Canine CK-MB mouse monoclonal antibody (mAb) |
Target/Biomarker | Canine Creatine Kinase MB (A1M) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine Creatine Kinase MB antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-A1M antibodies in A1M level test of animal Dog/Canine with Myocardial hypoxia. |
Tag | mFc |
Products description | Anti-Canine CK-MB mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-A1M antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-CK-MB-Ab03, GMP-CAN-CK-MB-Ab04 |
Product Name | Anti-Canine CK-MB human monoclonal antibody (mAb) |
Target/Biomarker | Canine Creatine Kinase MB (A1M) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Canine Creatine Kinase MB antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-A1M antibodies in A1M level test of animal Dog/Canine with Myocardial hypoxia. |
Tag | hFc |
Products description | Anti-Canine CK-MB human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-A1M antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Creatine Kinase-MB (CK-MB) stands as a pivotal enzyme biomarker within the intricate landscape of canine cardiology. It represents a specialized subtype of the enzyme creatine kinase (CK), which plays a fundamental role in energy metabolism, particularly in tissues with high-energy demands, such as skeletal and cardiac muscle. In dogs, CK-MB takes on a specific significance due to its primary localization within cardiac muscle cells. It exists in multiple isoforms, with the cardiac isoform CK-MB being predominantly found in the heart. The unique presence of CK-MB in cardiac muscle makes it a reliable and specific marker for assessing myocardial health. When cardiac muscle undergoes injury or stress, CK-MB is released into the bloodstream, where it becomes quantifiable. This phenomenon forms the basis for the use of CK-MB as an indicator of myocardial damage in dogs. The measurement of CK-MB levels plays a vital role in diagnosing various cardiac conditions and monitoring the response to treatment.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.